Acadia Healthcare director granted 6,331 shares

Cancelmi Daniel J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Cancelmi Daniel J reported acquisition or exercise transactions in this Form 4 filing.

Acadia Healthcare Company, Inc. director Daniel J. Cancelmi received a grant of 6,331 shares of common stock as reported on a Form 4. The award carried a stated price of $0.00 per share and is compensation-related rather than an open-market purchase or sale.

According to the disclosure, these shares will vest over a three-year period in equal annual installments beginning on May 6, 2027. Following this grant, Cancelmi directly holds a total of 12,956 Acadia Healthcare common shares, reflecting his updated equity stake as a company director.

Insider Trade Summary

Grant/Award: 6,331 shares

Grant/Award 1 txn

Insider Cancelmi Daniel J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,331	$0.00	$0.00

Holdings After Transaction: Common Stock — 12,956 shares (Direct)

Footnotes (1)

1. F1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.

Key Figures

Shares granted: 6,331 shares Grant price: $0.00 per share Total shares after grant: 12,956 shares +1 more

4 metrics

Shares granted 6,331 shares Grant/award of common stock to director Daniel J. Cancelmi

Grant price $0.00 per share Compensation-related stock award, not an open-market purchase

Total shares after grant 12,956 shares Direct Acadia Healthcare holdings following the transaction

Vesting schedule 3 years, equal installments Annual vesting beginning May 6, 2027

Key Terms

Grant, award, or other acquisition, vesting, Common Stock

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

vesting financial

"Shares will vest over a 3-year period in equal yearly installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ACHC disclose for Daniel J. Cancelmi?

Acadia Healthcare disclosed a stock grant to director Daniel J. Cancelmi. He received 6,331 shares of common stock as a compensation-related award, not an open-market purchase, bringing his direct holdings to 12,956 shares after the transaction.

How many Acadia Healthcare (ACHC) shares were granted to Daniel J. Cancelmi?

Daniel J. Cancelmi was granted 6,331 ACHC common shares. The Form 4 characterizes this as a grant or award acquisition at a stated price of $0.00 per share, reflecting equity-based compensation rather than a cash purchase in the market.

When will Daniel J. Cancelmi’s new ACHC shares vest?

The granted shares vest over three years in equal annual installments. Vesting begins on May 6, 2027, meaning a portion of the 6,331-share award will become fully owned each year over that three-year schedule, as described in the Form 4 footnote.

What is Daniel J. Cancelmi’s total ACHC shareholding after this grant?

After the grant, Daniel J. Cancelmi directly holds 12,956 shares. The Form 4 lists this as his total Acadia Healthcare common stock ownership following the award, showing his updated direct equity position as a company director.

Was the ACHC transaction a market buy or a compensation grant?

The transaction was a compensation-related grant, not a market buy. It is coded as an “A” transaction, described as a grant, award, or other acquisition with a $0.00 per-share price, indicating stock-based compensation rather than an open-market purchase.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/08/2026 - 05:01 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cancelmi Daniel J

(Last) (First) (Middle)

4020 ASPEN GROVE DRIVE, SUITE 900

(Street)

FRANKLIN TENNESSEE 37067

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ ACHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/06/2026		A		6,331(1)	A	$0.0	12,956	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.

	/s/ Brian Farley as Attorney in Fact for Daniel J. Cancelmi	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)